Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: A double-blind-placebo-controlled randomised trial

Creative Commons License

Aydogan M., Eifan A. O., Keles S., AKKOÇ T., Nursoy M. A., Bahceciler N. N., ...More

RESPIRATORY MEDICINE, vol.107, no.9, pp.1322-1329, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 107 Issue: 9
  • Publication Date: 2013
  • Doi Number: 10.1016/j.rmed.2013.06.021
  • Journal Name: RESPIRATORY MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1322-1329
  • Keywords: Allergy, Asthma, Conjunctivitis, Dust mite, Rhinitis, Sublingual immunotherapy, RHINITIS, ASTHMA, EFFICACY, CHILDHOOD, CONJUNCTIVITIS, PARAMETERS, EXTRACT, IMPACT
  • Open Archive Collection: AVESIS Open Access Collection
  • Kocaeli University Affiliated: Yes

Abstract

Background: Although sublingual immunotherapy (SLIT) has been demonstrated to be a safe and efficient treatment in children with seasonal allergic rhinitis (AR), there is little evidence on the efficacy of SLIT with house-dust-mite (HDM) extract in children with isolated perennial AR.